This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss
For any queries, please contact Customer Services or your Account Manager. Dismiss
News & Analysis (5)
-
April 02, 2026 | Comment Semaglutide patent expiry exposes global split on access, exclusivity
...Associates."...
Sections: Intellectual Property
-
March 20, 2026 | Comment India shifts from freeze to filter on China-linked foreign direct investment
...& Associates.The primary aim of Press Note 3, introduced in 2020 during the Covid-19 pandemic, was to...
Sections: DealRisk®, Mergers and Acquisitions, and Trade
-
December 15, 2025 | Comment Is IndiGo solely to blame for India's aviation meltdown, or are regulators at fault too?
...& Associates said.IndiGo’s meltdown stemmed from a crew-rostering failure driven by the DGCA’s revised...
Sections: Antitrust, DealRisk®, and Mergers and Acquisitions
Get the inside track, with MLex
With a global network of expert journalists digging deep into the areas of risk that matter to your business and clients—and the highest standards of impartiality—you can have complete trust in MLex to keep you ahead of the regulatory curve.
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from specialists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
TRY MLEX FREE FOR 14 DAYS
View full search results
Already a subscriber? Click here to login